$HTGM News

Last published 2y ago

2y agoHTGMHTG Molecular Diagnostics, Inc. - Appeal, Reversed with New Ground of RejectionUS Patent Trial and Appeal Board
3y agoHTGMHTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International ConventionGlobeNewswireTUCSON, Ariz., May 18, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a platform-based life science tools and drug discovery company, today announced that its management team will present
3y agoHTGMHTG Highlights the Advantages of Its Drug Discovery EngineGlobeNewswireTUCSON, Ariz., May 16, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported achievement of another technical
3y agoHTGMHTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business HighlightsGlobeNewswireTUCSON, Ariz., May 10, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported financial results for the quarter
3y agoHTGMHTG Provides Update on Drug Discovery Partnering InitiativeGlobeNewswireTUCSON, Ariz., April 25, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a platform-based life science tools and drug discovery company, today provided an update on partnering discussions
3y agoHTGMHTG Announces Key First Quarter Milestone Achievements for Drug DiscoveryGlobeNewswireTUCSON, Ariz., April 18, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a platform-based life science tools and drug discovery company, today announced the achievement of three
3y agoHTGMHTG Technology Featured in Numerous Scientific Posters at the AACR Annual Meeting April 16-19GlobeNewswireTUCSON, Ariz., April 06, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a platform-based life science tools and drug discovery company, today announced there will be at least four
3y agoHTGMHTG Provides a Year-End Update on its Drug Discovery Business and Attends LifeSci Partners 2023 Corporate Access EventGlobeNewswireTUCSON, Ariz., Jan. 09, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced
3y agoHTGMHTG Announces Certain Preliminary 2022 Unaudited Financial ResultsGlobeNewswirePreliminary full year 2022 unaudited revenue of $6.4 million Cash and cash equivalents of $12.2 million as of December 31, 2022 TUCSON, Ariz., Jan. 06, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc.
3y agoHTGMHTG Molecular Diagnostics Provides Highlights of its Second Event in Drug Discovery KOL Webcast SeriesGlobeNewswireTUCSON, Ariz., Dec. 28, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced
3y agoHTGMHTG Molecular Diagnostics Announces Closing of a $10 Million Public OfferingGlobeNewswireTUCSON, Ariz., Dec. 23, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced
3y agoHTGMHTG Molecular Diagnostics Announces Pricing of a $10 Million Public OfferingGlobeNewswireTUCSON, Ariz., Dec. 21, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced
3y agoHTGMHTG Announces One-for-Twelve Reverse Stock SplitGlobeNewswireTUCSON, Ariz., Dec. 20, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced
3y agoHTGMHTG Molecular Diagnostics Announces the Next Event in its RNA Profiling in Drug Discovery KOL Webcast SeriesGlobeNewswireTUCSON, Ariz., Dec. 09, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced
3y agoHTGMHTG Technology Featured Across Numerous Abstracts at Upcoming Scientific ConferencesGlobeNewswireTUCSON, Ariz., Dec. 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced
4y agoHTGMHTG Molecular Diagnostics Reports Third Quarter 2022 ResultsGlobeNewswireTUCSON, Ariz., Nov. 10, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced
4y agoHTGMHTG to Collaborate With OmiCure, Providing Transcriptomic Data Across Several Cancer IndicationsGlobeNewswireTUCSON, Ariz. and PARIS, Oct. 26, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling
4y agoHTGMHTG Provides Update on Third Quarter Progress Toward Its Transcriptome-Informed Approach to Drug DiscoveryGlobeNewswireTUCSON, Ariz., Oct. 12, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology,
4y agoHTGMHTG Molecular Diagnostics to Participate in the Cantor Fitzgerald Oncology, Hematology & HemeOnc ConferenceGlobeNewswireTUCSON, Ariz., Sept. 26, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that management
4y agoHTGMThe Fundación Instituto Valenciano de Oncología Leverages HTG Technology for Breast Cancer Laboratory-Developed TestGlobeNewswireTUCSON, Ariz., Sept. 20, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that the Fundación Ins
4y agoHTGMHTG Molecular Diagnostics Reports Second Quarter 2022 ResultsGlobeNewswireTUCSON, Ariz., Aug. 11, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today reported recent business hig
4y agoHTGMHTG Molecular Diagnostics to Announce Q2 2022 Financial Results and Host Conference Call on Thursday, August 11GlobeNewswireTUCSON, Ariz., Aug. 04, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that it will repor
4y agoHTGMHTG Molecular Diagnostics Hosting a KOL Event Addressing Drug Candidate AttritionGlobeNewswireTUCSON, Ariz., July 19, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that it will host
4y agoHTGMHTG Molecular Diagnostics Announces Amendment to Senior Loan FacilityGlobeNewswireTUCSON, Ariz., July 18, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced it has entered int
4y agoHTGMHTG Releases Second Whitepaper for its Transcriptome-Informed Approach to Drug DiscoveryGlobeNewswireTUCSON, Ariz., July 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, has released a second white paper
4y agoHTGMPublication Highlights Potential Clinical Applications of the HTG Transcriptome Panel in Bladder CancerGlobeNewswireTUCSON, Ariz., June 29, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced the customer publication
4y agoHTGMHTG to Sponsor Keynote Presentation Featuring Customer Use of its HTG EdgeSeq Technology in Clinical TrialsGlobeNewswireTUCSON, Ariz., June 08, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that it will be sponsori
4y agoHTGMHTG Technology Featured in Multiple Scientific Abstracts Highlighting Novel Applications in Precision Medicine at ASCO 2022GlobeNewswireTUCSON, Ariz., June 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced its HTG EdgeSeq te
4y agoHTGMHTG to Host Scientific Webinar Featuring Customer Use of the HTG Transcriptome Panel in Preclinical and Clinical ProgramsGlobeNewswireTUCSON, Ariz., June 01, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that it will be hosting
4y agoHTGMHTG Molecular Diagnostics to Participate in the H.C. Wainwright Global Investment ConferenceGlobeNewswireTUCSON, Ariz., May 17, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that management wil
4y agoHTGMHTG Molecular Diagnostics Reports First Quarter 2022 ResultsGlobeNewswireTUCSON, Ariz., May 12, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today reported recent business high
4y agoHTGMHTG Molecular Diagnostics to Announce Q1 2022 Financial Results and Host Conference Call on Thursday, May 12GlobeNewswireTUCSON, Ariz., May 05, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that it will report
4y agoHTGMHTG Expands Therapeutics TeamGlobeNewswireTUCSON, Ariz., April 13, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced it has expanded its the
4y agoHPQ HTGM MDVL MNTS+1Thinking about buying stock in HTG Molecular Diagnostics, Medavail, Momentus, System1, or HP?PR NewswireNEW YORK, April 7, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HTGM, MDVL, MNTS, SST, and HPQ. To
4y agoHTGMHTG Expands Features of Proprietary HTG EdgeSeq TechnologyGlobeNewswireTUCSON, Ariz., April 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that it has improved th
4y agoHTGMHTG Releases Proof-of-Approach Whitepaper Establishing Utility of Transcriptome-Informed Approach to Drug DiscoveryGlobeNewswireTUCSON, Ariz., March 31, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, has released its first proof-of-a
4y agoHTGMHTG Molecular Diagnostics Reports Full Year 2021 ResultsGlobeNewswireTUCSON, Ariz., March 29, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today reported its financial resu
4y agoHTGMHTG Molecular Diagnostics to Announce Year End 2021 Financial Results and Host Conference Call on Tuesday, March 29GlobeNewswireTUCSON, Ariz., March 22, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that it will repo
4y agoHTGMHTG Molecular Diagnostics Announces $7.5 Million Private PlacementGlobeNewswireTUCSON, Ariz., March 18, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has entered into a definitive securities purchase agre
4y agoHTGMHTG Names Renowned RNA Expert Dr. Robert Spitale to Therapeutics Scientific Advisory BoardGlobeNewswireTUCSON, Ariz., Feb. 03, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced it has appointed Robert
4y agoHTGM PIRSHTG Appoints Biopharmaceutical Industry Veteran Christopher Kiritsy to its Board of DirectorsGlobeNewswireTUCSON, Ariz., Jan. 28, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced it has appointed biophar
4y agoHTGMHTG Molecular Diagnostics Announces Certain Preliminary 2021 Unaudited Financial ResultsGlobeNewswirePreliminary full year 2021 unaudited revenue of $8.9 million Cash, cash equivalents and short-term marketable securities of $21.9 million as of December 31, 2021 TUCSON, Ariz., Jan. 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (N
4y agoHTGMHTG Completes HTP Product Next-Phase Development MilestoneGlobeNewswireTUCSON, Ariz., Dec. 22, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, has now expanded the potential mar
4y agoHTGMHTG Expands Therapeutics Scientific Advisory Board With Addition of Dr. Jerald RadichGlobeNewswireTUCSON, Ariz., Dec. 16, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that internationally ren
4y agoHTGMHTG Announces Major Sales Milestone for HTG Transcriptome PanelGlobeNewswireTUCSON, Ariz., Dec. 09, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that it has exceeded $1
4y agoHTGMHTG and Icahn School of Medicine at Mount Sinai Announce Bladder Cancer Research CollaborationGlobeNewswireTUCSON, Ariz., Nov. 17, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, and the Icahn School of Medicine a
4y agoHTGMHTG Molecular Diagnostics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireTUCSON, Ariz., Nov. 15, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that, on November
5y agoHTGMHTG Molecular Diagnostics Reports Third Quarter 2021 ResultsGlobeNewswireTUCSON, Ariz., Nov. 10, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today reported its financial resul
5y agoHTGMHTG Molecular Diagnostics to Announce Third Quarter 2021 Financial Results and Host Conference Call on Wednesday, November 10GlobeNewswireTUCSON, Ariz., Nov. 02, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), a life science company advancing precision medicine through its transcriptome-wide technology, today announced that it will report its financial results for
5y agoHTGMHTG Expands Therapeutics TeamGlobeNewswireTUCSON, Ariz., Oct. 05, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced it has expanded its ther